Extensión del IVDR: ¿Qué Implica para Ti?

    Regulatory Affairs

    IVDR Extension: What Does This Mean for You?

    The IVDR transition timelines have been extended, but that does not mean manufacturers can put compliance on hold.

    Discover what Regulation (EU) 2024/1860 means for your IVD portfolio, which requirements and deadlines you need to consider, and how to use the additional time effectively.

    Prepare your transition strategy and stay on track towards IVDR compliance.

    IVDR extension

    About This White Paper

    Regulation (EU) 2024/1860 introduced extended transitional periods for certain IVDs, giving manufacturers additional time to transition from the IVDD to the IVDR. However, benefiting from these extensions requires manufacturers to meet specific conditions and milestones, including an IVDR-compliant QMS and timely engagement with a Notified Body.

    This white paper explains what the amended timelines mean in practice and why the extension should be viewed as an opportunity to accelerate, rather than postpone, IVDR readiness. It explores the key areas manufacturers need to address, from technical documentation and clinical evidence to PMS, PMPF and Quality Management Systems.

    You will also discover practical strategies for identifying compliance gaps, prioritizing your portfolio and building a structured transition plan towards IVDR compliance.

    Key Takeaways

    ✓ Understand the Extended IVDR Transition Timelines. Get a clear overview of the amended transitional provisions under Regulation (EU) 2024/1860, including the different milestones for Class D, Class C and Class B/Class A sterile IVDs.

    ✓ Know the Conditions Behind the Extension. Understand the prerequisites manufacturers must meet to benefit from the extended transition periods, including continued IVDD compliance, restrictions on significant changes and the requirement for an IVDR-compliant QMS.

    ✓ Turn Extra Time Into an IVDR Transition Strategy. Learn why postponing your compliance efforts can create regulatory bottlenecks, resource constraints and challenges with Notified Body capacity, and why manufacturers should keep their transition moving.

    ✓ Build IVDR-Compliant Technical Documentation. Discover why the new application deadlines should effectively be treated as deadlines for having your technical documentation ready, and how gap assessments, remediation plans and submission strategies can help you prepare.

    ✓ Strengthen Your PMS and PMPF Approach. Explore how robust post-market surveillance and post-market performance follow-up processes help monitor real-world device performance, identify emerging risks and maintain compliance throughout the product lifecycle.

    ✓ Address Clinical Evidence Gaps Before They Become Roadblocks. Understand the importance of scientific validity, state-of-the-art evidence, performance evaluation and a clear link between performance data and benefit-risk evaluation under the IVDR.

    ✓ Align Your QMS With IVDR Requirements. Learn why ISO 13485 certification alone does not automatically mean your QMS is IVDR-compliant, and which additional regulatory processes need to be incorporated into your quality system.

    ✓ Create a Practical Roadmap Towards IVDR Compliance. See how regulatory strategy, gap assessment, portfolio prioritization, remediation, mock audits and technical documentation assessment can come together in a structured IVDR transition approach.

    Download now

    First name*

    Last name*

    Role*

    Please SelectC-level / VPDirector(Sr.) ManagerSpecialist/AnalystIntern/ApprenticeIndividual contributorOther

    Department*

    Please SelectStrategy & ManagementRegulatory & VigilanceQuality Assurance & ControlIT & Digital InnovationManufacturing & ProductionProduct DevelopmentResearch & InnovationClinical Affairs & OperationsMedical AffairsMarket AccessSales & MarketingHRProcurementOther

    Professional Email*

    Company name*

    Industry*

    Please SelectMedical DevicesIn Vitro DiagnosticsPharmaBiotechAnimal HealthService providerConsumer HealthOther

    Country*

    Please SelectAfghanistanÅland IslandsAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAsia/Pacific RegionAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCaribbean NetherlandsCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosCongoCook IslandsCosta RicaCote d'IvoireCroatiaCubaCuraçaoCyprusCzech RepublicDemocratic Republic of the CongoDenmarkDjiboutiDominicaDominican RepublicEast TimorEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaEuropeFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern and Antarctic LandsGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacauMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmar (Burma)NamibiaNauruNepalNetherlandsNetherlands AntillesNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth KoreaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestinePanamaPapua New GuineaParaguayPeruPhilippinesPitcairn IslandsPolandPortugalPuerto RicoQatarRéunionRomaniaRussiaRwandaSaint BarthélemySaint HelenaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth KoreaSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluU.S. Virgin IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUnited States Minor Outlying IslandsUruguayUzbekistanVanuatuVatican CityVenezuelaVietnamWallis and FutunaWestern SaharaYemenZambiaZimbabwe

    Content Title

    Content Type

    Content Division

    Content Industry

    QbD Group is committed to protecting and respecting your privacy, and we’ll use your personal information to administer your account and to provide the products and services you requested from us.

    • Yes, I agree to receive personalized newsletters with market insights, invitations for exclusive events and educational webinars from the QbD Group.

    • I consent to the privacy policy and understand that my personal data will be stored and processed